German biotech BioNTech (Nasdaq: BNTX) saw its shares dip 3.4% to $101.44 today, after it reported financial results for the ...

US subsidiary and Iceland-based Alvotech (Nasdaq: ALVO) today announced that the US Food and Drug Administration (FDA) has ...

T-cell immunotherapies (TCI) are redefining cancer care, with chimeric antigen receptor T-cell (CAR-T) therapies witnessing ...

Sweden’s Mendus (STO: IMMU), a clinical-stage drug developer, has announced the appointment of Dr Tariq Mughal as chief ...

The introduction of outpatient flat-rate payments approved today by the Swiss Federal Council poses significant risks for ...

In the USA, the Trump administration is urging congressional Republicans to include a “most favored nation” (MFN) policy in ...

US biotech Biohaven last week received a commitment from Oberland Capital to invest up to $600 million in the company. Also, ...

Kissei Pharmaceutical is a Japanese research and development focused corporation. It aims to push advances in cutting-edge research in areas such as biotechnology-based medicine and even further ...

Danish allergy immunotherapy specialist ALK Abello (OMX: ALK B) has announced a four-year agreement with USA-based ARS ...

The US Department of Health and Human Services (HHS) and the National Institutes for Health (NIH) have announced a $500 ...

A biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Based in Maryland, USA, the firm is a former Shire subsidiary ...

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containment of chronic ...